Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Amryt Pharma plc AMYT
$14.70
На 18:02, 12 мая 2023
-1.36%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
942768330.00000000
-
week52high
14.77
-
week52low
6.41
-
Revenue
222543000
-
P/E TTM
-47
-
Beta
0.76497100
-
EPS
0.37000000
-
Last Dividend
0.00000000
-
Next Earnings Date
02 мар 2022 г. в 07:00
Описание компании
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| SVB Leerink | Outperform | Outperform | 24 июн 2022 г. |
| SVB Leerink | Outperform | Outperform | 05 мая 2022 г. |
| SVB Leerink | Outperform | Outperform | 10 мар 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 10 мар 2022 г. |
| SVB Leerink | Outperform | Outperform | 23 ноя 2021 г. |
| Maxim Group | Hold | Buy | 10 янв 2023 г. |
| Cantor Fitzgerald | Neutral | Overweight | 10 янв 2023 г. |
| Canaccord Genuity | Hold | Buy | 10 янв 2023 г. |
| SVB Leerink | Market Perform | Outperform | 09 янв 2023 г. |
| HC Wainwright & Co. | Neutral | Buy | 18 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Why Shares of Amryt Pharma Jumped This Week
The Motley Fool
12 янв 2023 г. в 15:32
A takeover bid by an Italian pharmaceutical and healthcare company boosted Amryt's shares.
Acquisition Of Amryt Pharma: How To Profit From Orphan Drugs Developers
Seeking Alpha
12 янв 2023 г. в 13:52
Amryt Pharma plc will be acquired by Chiesi Farmaceutici S.p.A. Amryt Pharma is valued at $1.25 billion plus $225 million upon achievement of certain pipeline development milestones.
New Strong Sell Stocks for December 7th
Zacks Investment Research
07 дек 2022 г. в 08:17
ABST, AMYT and ARCE have been added to the Zacks Rank #5 (Strong Sell) List on December 7, 2022.
New Strong Sell Stocks for November 17th
Zacks Investment Research
17 ноя 2022 г. в 09:02
BRFS, AOS and AMYT have been added to the Zacks Rank #5 (Strong Sell) List on November 17, 2022.
New Strong Sell Stocks for November 16th
Zacks Investment Research
16 ноя 2022 г. в 09:02
EGO, BRFS and AMYT have been added to the Zacks Rank #5 (Strong Sell) List on November 16, 2022.